Abiopharma

🔍 Chandrasekaran Nagasubramaniyan (Executive)

Company: INTEL CORP (INTC)

Report Date: 2026-07-30

Detailed Transactions and Holdings:

• Acquired 33,007 shares of Common Stock (Direct)
  Date: 2026-07-30 | Code: M | equity_swap_involved: 0 | shares_owned_after: 238,859.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 14,738 shares of Common Stock at $90.04 per share (Direct)
  Date: 2026-07-30 | Code: F | equity_swap_involved: 0 | shares_owned_after: 224,121.00 | transaction_form_type: 4
• Sold 33,007 shares of Restricted Stock Units (Derivative)
  Date: 2026-07-30 | Code: M | equity_swap_involved: 0 | shares_owned_after: 33,008.00 | transaction_form_type: 4 | Footnotes: F1, F1, F2, F2

Footnotes:

• F1: Each restricted stock unit (RSU) represents the right to receive, following vesting, one share of Intel common stock.
• F2: Unless earlier forfeited under the terms of the RSU, 1/8th of the award vests and converts into common stock in eight substantially equal quarterly tranches, beginning on January 30, 2025. If the quarterly vesting date falls on a non-business date, the next business date shall apply.